View the LORLAMAKS 25 registration information details.
Back to drug list
ItemsDrug Registration information
ID936
No936
Brand NameLORLAMAKS 25
IngredientsLORLATINIB 25 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack Size30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE (AKL) POSITIVE MATASTATIC NSCLC
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT GREY, ROUND FILM COATED TABLET
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY No.2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 L 1045/23
FDD Registration Date15/12/2023
Expiry Date14/12/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA